Bimolane: Structure Determination Indicates Anticancer Activity Is Attributable to ICRF-154
- 14 September 1984
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 225 (4667) , 1165-1166
- https://doi.org/10.1126/science.6474171
Abstract
X-ray diffraction studies of crystals from samples of bimolane synthesized in China and in the United States showed that the crystals consist of the related compound ICRF-154. Analysis of the results of biological tests did not show any significant differences between the anticancer activity of bimolane and ICRF-154. It appears that the anticancer activity of bimolane is due to ICRF-154.This publication has 6 references indexed in Scilit:
- Stereochemistry of conformationally restricted analogs of the antitumor agent ICRF-159. 2. Structures of antimetastatically active and inactive isomers of a tricyclic analogJournal of the American Chemical Society, 1983
- Stereochemistry of the antitumor agent 4,4'-(1,2-propanediyl)bis(4-piperazine-2,6-dione): crystal and molecular structures of the racemate (ICRF-159) and a soluble enantiomer (ICRF-187)Journal of the American Chemical Society, 1982
- Stereochemistry of conformationally restricted analogs of the antitumor agent ICRF-159: crystal and molecular structures of cis- and trans-cyclopropylbis(dioxopiperazine)Journal of the American Chemical Society, 1982
- New Fluorinated Pesticides Have Delayed ActivitiesScience, 1981
- A New Multipurpose Drug From ChinaScience, 1981
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969